Joanne Lysaght

4.5k total citations
95 papers, 3.3k citations indexed

About

Joanne Lysaght is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Joanne Lysaght has authored 95 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 40 papers in Immunology and 35 papers in Surgery. Recurrent topics in Joanne Lysaght's work include Cancer Immunotherapy and Biomarkers (32 papers), Esophageal Cancer Research and Treatment (29 papers) and Immune Cell Function and Interaction (24 papers). Joanne Lysaght is often cited by papers focused on Cancer Immunotherapy and Biomarkers (32 papers), Esophageal Cancer Research and Treatment (29 papers) and Immune Cell Function and Interaction (24 papers). Joanne Lysaght collaborates with scholars based in Ireland, Canada and United Kingdom. Joanne Lysaght's co-authors include John V. Reynolds, Claire L. Donohoe, Graham P. Pidgeon, Suzanne L. Doyle, Melissa J. Conroy, Stephen Todryk, Kingston H. G. Mills, Andrew Jarnicki, Jacintha O’Sullivan and Adriele Prina‐Mello and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Joanne Lysaght

94 papers receiving 3.3k citations

Peers

Joanne Lysaght
Joanne Lysaght
Citations per year, relative to Joanne Lysaght Joanne Lysaght (= 1×) peers Shuxia Wang

Countries citing papers authored by Joanne Lysaght

Since Specialization
Citations

This map shows the geographic impact of Joanne Lysaght's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Lysaght with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Lysaght more than expected).

Fields of papers citing papers by Joanne Lysaght

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Lysaght. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Lysaght. The network helps show where Joanne Lysaght may publish in the future.

Co-authorship network of co-authors of Joanne Lysaght

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Lysaght. A scholar is included among the top collaborators of Joanne Lysaght based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Lysaght. Joanne Lysaght is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davern, Maria, Noel E. Donlon, Dara Bracken‐Clarke, et al.. (2024). Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma. Biomedicines. 12(4). 819–819. 2 indexed citations
2.
Moran, Brendan, Maria Davern, John V. Reynolds, Noel E. Donlon, & Joanne Lysaght. (2023). The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy. Cancer Letters. 559. 216121–216121. 40 indexed citations
4.
Davern, Maria, Noel E. Donlon, Fiona O’Connell, et al.. (2022). Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy. Journal of Cancer Research and Clinical Oncology. 149(8). 5377–5395. 14 indexed citations
5.
Davern, Maria, Noel E. Donlon, Conall Hayes, et al.. (2022). FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy. Journal of Cancer Research and Clinical Oncology. 149(7). 3753–3774. 1 indexed citations
6.
Davern, Maria, Noel E. Donlon, Conall Hayes, et al.. (2021). Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells. Translational Oncology. 14(6). 101062–101062. 12 indexed citations
7.
Donlon, Noel E., Maria Davern, Robert Power, et al.. (2021). The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling. Cancers. 13(16). 4005–4005. 4 indexed citations
8.
9.
Donlon, Noel E., Maria Davern, Fiona O’Connell, et al.. (2020). Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines. Cancers. 12(11). 3356–3356. 15 indexed citations
10.
Melo, Ashanty M., Stephen G. Maher, Seónadh M. O’Leary, Derek G. Doherty, & Joanne Lysaght. (2020). Selective effects of radiotherapy on viability and function of invariant natural killer T cells in vitro. Radiotherapy and Oncology. 145. 128–136. 3 indexed citations
11.
Melo, Ashanty M., Melissa J. Conroy, Eamon P. Breen, et al.. (2020). CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies. Cancer Immunology Immunotherapy. 69(6). 969–982. 9 indexed citations
12.
Lysaght, Joanne. (2019). The ‘obesity paradox’ in action with cancer immunotherapy. Nature Reviews Endocrinology. 15(3). 132–133. 15 indexed citations
13.
14.
Melo, Ashanty M., Lei Zhang, Andreea Petrasca, et al.. (2018). Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells. Glycobiology. 28(7). 512–521. 13 indexed citations
15.
Conroy, Melissa J., Karen Galvin, Suzanne L. Doyle, et al.. (2016). Parallel Profiles of Inflammatory and Effector Memory T Cells in Visceral Fat and Liver of Obesity-Associated Cancer Patients. Inflammation. 39(5). 1729–1736. 18 indexed citations
16.
Conroy, Melissa J., et al.. (2014). Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment. Frontiers in Oncology. 4. 107–107. 68 indexed citations
17.
Allott, Emma H., Elizabeth Oliver, Joanne Lysaght, et al.. (2012). The SGBS cell strain as a model for the in vitro study of obesity and cancer. Clinical & Translational Oncology. 14(10). 774–782. 30 indexed citations
18.
Lysaght, Joanne, Navin Kumar Verma, Jacqueline Ryan, et al.. (2012). The microtubule targeting agent PBOX-15 inhibits integrin-mediated cell adhesion and induces apoptosis in acute lymphoblastic leukaemia cells. International Journal of Oncology. 42(1). 239–246. 9 indexed citations
19.
Doyle, Suzanne L., Claire L. Donohoe, Stephen P. Finn, et al.. (2011). IGF-1 and Its Receptor in Esophageal Cancer: Association with Adenocarcinoma and Visceral Obesity. The American Journal of Gastroenterology. 107(2). 196–204. 85 indexed citations
20.
Lynam‐Lennon, Niamh, John V. Reynolds, Graham P. Pidgeon, et al.. (2010). Alterations in DNA Repair Efficiency are Involved in the Radioresistance of Esophageal Adenocarcinoma. Radiation Research. 174(6a). 703–711. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026